Literature DB >> 26208624

From a binary salt to salt co-crystals of antibacterial agent lomefloxacin with improved solubility and bioavailability.

Zhi-Hui Zhang1, Qi Zhang1, Qing-Qing Zhang1, Chen Chen1, Ming-Yang He1, Qun Chen1, Guo-Qiang Song2, Xiao-Peng Xuan3, Xian-Feng Huang2.   

Abstract

The cocrystallization of lomefloxacin (Lf) with barbituric acid (HBA) and/or isophthalic acid (H2ip) leads to novel binary and ternary salts via hydrogen-bonding recognition. X-ray single-crystal diffraction analyses show that zwitterionic lomefloxacin can adjust itself to fulfill a different supramolecular array in either binary salts or ternary salt co-crystals, formulated as [HLf]·[Hip]·H2O (1), [HLf]·[BA]·[HBA]·H2O (2) and [HLf]·[BA]·[H2ip]·CH3OH·H2O (3). These pharmaceutical agents present uniform charge-assisted hydrogen-bonding networks between HLf cations and acidic coformers with the lattice capturing water molecules. Structural comparison of (2) and (3) indicated that a delicate balance of geometries and hydrogen-bonding partners is required for stacking to favor the formation of ternary salt co-crystals. Cocrystallization was able to overcome the water insolubility of lomefloxacin. Both the salt co-crystals display enhanced solubility and better pharmaceutical applicability.

Entities:  

Keywords:  active pharmaceutical ingredients (APIs); cocrystallization; lomefloxacin; salt co-crystals; solubility

Mesh:

Substances:

Year:  2015        PMID: 26208624     DOI: 10.1107/S2052520615011191

Source DB:  PubMed          Journal:  Acta Crystallogr B Struct Sci Cryst Eng Mater        ISSN: 2052-5192


  1 in total

1.  Crystal structure of (RS)-4-(3-carb-oxy-1-ethyl-6,8-di-fluoro-4-oxo-1,4-di-hydro-quinolin-7-yl)-2-methyl-piperazin-1-ium 3-carb-oxy-5-fluoro-benzoate.

Authors:  Sheng Feng; Gui-Liang Zhu; Jia-Jia Sun; Chen Chen; Zhi-Hui Zhang
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2019-01-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.